Genetically predicted circulating vitamin C in relation to cardiovascular disease

European Journal of Preventive Cardiology - Tập 28 Số 16 - Trang 1829-1837 - 2022
Shuai Yuan1, Ju‐Sheng Zheng2,3, Amy M. Mason4,5, Stephen Burgess6,7, Susanna C. Larsson1,8
1Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, Stockholm 17177, Sweden
2Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Shilongshan Road 18, Cloud Town, Xihu District, Hangzhou, China
3Westlake Laboratory of Life Sciences and Biomedicine, Shilongshan Road 18, Cloud Town, Xihu District, Hangzhou, China
4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Wort’s Causeway, Cambridge, CB1 8RN, UK
5National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Hills Road, Cambridge CB2 0QQ, UK
6Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK
7MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Forvie Site, Robinson Way, Cambridge Biomedical Campus Cambridge, CB2 0SR, UK
8Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Akademiska sjukhuset, ingång 78, 1tr, 751 85 Uppsala, Sweden

Tóm tắt

AbstractAim

We conducted a two-sample Mendelian randomization (MR) study to assess the associations of genetically predicted circulating vitamin C levels with cardiovascular diseases (CVDs).

Methods and results

Ten lead single-nucleotide polymorphisms associated with plasma vitamin C levels at the genome-wide significance level were used as instrumental variables. Summary-level data for 15 CVDs were obtained from corresponding genetic consortia, the UK Biobank study, and the FinnGen consortium. The inverse-variance-weighted method was the primary analysis method, supplemented by the weighted median and MR-Egger methods. Estimates for each CVD from different sources were combined. Genetically predicted vitamin C levels were not associated with any CVD after accounting for multiple testing. However, there were suggestive associations of higher genetically predicted vitamin C levels (per 1 standard deviation increase) with lower risk of cardioembolic stroke [odds ratio, 0.79; 95% confidence interval (CI), 0.64, 0.99; P = 0.038] and higher risk of atrial fibrillation (odds ratio, 1.09; 95% CI, 1.00, 1.18; P = 0.049) in the inverse-variance-weighted method and with lower risk of peripheral artery disease (odds ratio, 0.76, 95% CI, 0.62, 0.93; P = 0.009) in the weighted median method.

Conclusion

We found limited evidence with MR techniques for an overall protective role of vitamin C in the primary prevention of CVD. The associations of vitamin C levels with cardioembolic stroke, atrial fibrillation, and peripheral artery disease need further study.

Từ khóa


Tài liệu tham khảo

Li, 2007, New developments and novel therapeutic perspectives for vitamin C, J Nutr, 137, 2171, 10.1093/jn/137.10.2171

Münzel, 2010, Is oxidative stress a therapeutic target in cardiovascular disease?, Eur Heart J, 31, 2741, 10.1093/eurheartj/ehq396

Moser, 2016, Vitamin C and heart health: a review based on findings from epidemiologic studies, Int J Mol Sci, 17, 1328, 10.3390/ijms17081328

Khaw, 2001, Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition, Lancet, 357, 657, 10.1016/S0140-6736(00)04128-3

Osganian, 2003, Vitamin C and risk of coronary heart disease in women, J Am Coll Cardiol, 42, 246, 10.1016/S0735-1097(03)00575-8

Pfister, 2011, Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition-Norfolk prospective study, Am Heart J, 162, 246, 10.1016/j.ahj.2011.05.007

Simon, 2001, Relation of serum ascorbic acid to mortality among US adults, J Am Coll Nutr, 20, 255, 10.1080/07315724.2001.10719040

Morelli, 2020, Vitamin C and cardiovascular disease: an update, Antioxidants (Basel), 9, 1227, 10.3390/antiox9121227

Zhu, 2020, Targets of vitamin C with therapeutic potential for cardiovascular disease and underlying mechanisms: a study of network pharmacology, Front Pharmacol, 11, 591337, 10.3389/fphar.2020.591337

Al-Khudairy, 2017, Vitamin C supplementation for the primary prevention of cardiovascular disease, Cochrane Database Syst Rev, 3, Cd011114

Myung, 2013, Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials, BMJ, 346, f10, 10.1136/bmj.f10

Nielsen, 2018, Biobank-driven genomic discovery yields new insight into atrial fibrillation biology, Nat Genet, 50, 1234, 10.1038/s41588-018-0171-3

van der Harst, 2018, Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease, Circ Res, 122, 433, 10.1161/CIRCRESAHA.117.312086

Shah, 2020, Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure, Nat Commun, 11, 163, 10.1038/s41467-019-13690-5

Malik, 2018, Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes, Nat Genet, 50, 524, 10.1038/s41588-018-0058-3

Woo, 2014, Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage, Am J Hum Genet, 94, 511, 10.1016/j.ajhg.2014.02.012

Sudlow, 2015, UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age, PLoS Med, 12, e1001779, 10.1371/journal.pmed.1001779

2020

Zheng, 2021, Plasma vitamin C and type 2 diabetes: genome-wide association study and Mendelian randomization analysis in European populations, Diabetes Care, 44, 98, 10.2337/dc20-1328

Kobylecki, 2015, Genetically high plasma vitamin C, intake of fruit and vegetables, and risk of ischemic heart disease and all-cause mortality: a Mendelian randomization study, Am J Clin Nutr, 101, 1135, 10.3945/ajcn.114.104497

Yuan, 2019, Plasma phospholipid fatty acids, FADS1 and risk of 15 cardiovascular diseases: a Mendelian randomisation study, Nutrients, 11, 3001, 10.3390/nu11123001

Burgess, 2017, Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants, Epidemiology, 28, 30, 10.1097/EDE.0000000000000559

Bowden, 2016, Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator, Genet Epidemiol, 40, 304, 10.1002/gepi.21965

Bowden, 2015, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression, Int J Epidemiol, 44, 512, 10.1093/ije/dyv080

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186

Spiller, 2019, Software application profile: mrrobust—a tool for performing two-sample summary Mendelian randomization analyses, Int J Epidemiol, 48, 684, 10.1093/ije/dyy195

Rimm, 1993, Vitamin E consumption and the risk of coronary heart disease in men, N Engl J Med, 328, 1450, 10.1056/NEJM199305203282004

Ascherio, 1999, Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States, Ann Intern Med, 130, 963, 10.7326/0003-4819-130-12-199906150-00003

Larsson, 2018, Serum magnesium levels and risk of coronary artery disease: Mendelian randomisation study, BMC Med, 16, 68, 10.1186/s12916-018-1065-z

Larsson, 2019, Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study, Neurology, 92, e944, 10.1212/WNL.0000000000007001

Pearson, 2017, Vitamin C status correlates with markers of metabolic and cognitive health in 50-year-olds: findings of the CHALICE cohort study, Nutrients, 9, 831, 10.3390/nu9080831

Aune, 2017, Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies, Int J Epidemiol, 46, 1029, 10.1093/ije/dyw319

Wang, 2014, Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies, BMJ, 349, g4490, 10.1136/bmj.g4490

Myint, 2008, Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study, Am J Clin Nutr, 87, 64, 10.1093/ajcn/87.1.64

Sesso, 2008, Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial, JAMA, 300, 2123, 10.1001/jama.2008.600

Erbs, 2003, Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy, Am Heart J, 146, 280, 10.1016/S0002-8703(03)00184-4

Pfister, 2014, Plasma vitamin C and risk of hospitalisation with diagnosis of atrial fibrillation in men and women in EPIC-Norfolk prospective study, Int J Cardiol, 177, 830, 10.1016/j.ijcard.2014.11.016

Hemilä, 2017, Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis, BMC Cardiovasc Disord, 17, 49, 10.1186/s12872-017-0478-5

Kobylecki, 2018, Genetically high plasma vitamin C and urate: a Mendelian randomization study in 106 147 individuals from the general population, Rheumatology (Oxford), 57, 1769, 10.1093/rheumatology/key171